As Children’s Eye Health and Safety Month comes to a close, we want to shout out to all the researchers that are conducting groundbreaking pre-clinical studies, worldwide, to pioneer advancements in pediatric eye health. To all of you, thank you for your incredible work that is paving the way for better outcomes and brighter futures
23.06
2020
Targeting VEGF164 in Müller cells may be useful to treat retinopathy of prematurity
In Nature’s Scientific Reports, Becker et al use the Phoenix MICRON® IV, OCT, and focal ERG to assess the therapeutic value of knocking down a splice variant of VEGF in Müller cells in a model of Retinopathy of Prematurity (ROP). ROP is characterized by delayed vascularization of the retina after disrupted oxygen levels, followed by